JP2022506110A5 - - Google Patents

Info

Publication number
JP2022506110A5
JP2022506110A5 JP2021523278A JP2021523278A JP2022506110A5 JP 2022506110 A5 JP2022506110 A5 JP 2022506110A5 JP 2021523278 A JP2021523278 A JP 2021523278A JP 2021523278 A JP2021523278 A JP 2021523278A JP 2022506110 A5 JP2022506110 A5 JP 2022506110A5
Authority
JP
Japan
Application number
JP2021523278A
Other languages
Japanese (ja)
Other versions
JP2022506110A (ja
JPWO2020092592A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/058896 external-priority patent/WO2020092592A1/en
Publication of JP2022506110A publication Critical patent/JP2022506110A/ja
Publication of JPWO2020092592A5 publication Critical patent/JPWO2020092592A5/ja
Publication of JP2022506110A5 publication Critical patent/JP2022506110A5/ja
Priority to JP2024185222A priority Critical patent/JP2025011310A/ja
Pending legal-status Critical Current

Links

JP2021523278A 2018-10-30 2019-10-30 治療用化合物および組成物 Pending JP2022506110A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024185222A JP2025011310A (ja) 2018-10-30 2024-10-21 治療用化合物および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862752503P 2018-10-30 2018-10-30
US62/752,503 2018-10-30
PCT/US2019/058896 WO2020092592A1 (en) 2018-10-30 2019-10-30 Therapeutic compounds and compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024185222A Division JP2025011310A (ja) 2018-10-30 2024-10-21 治療用化合物および組成物

Publications (3)

Publication Number Publication Date
JP2022506110A JP2022506110A (ja) 2022-01-17
JPWO2020092592A5 JPWO2020092592A5 (https=) 2022-10-28
JP2022506110A5 true JP2022506110A5 (https=) 2022-10-28

Family

ID=70464752

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021523278A Pending JP2022506110A (ja) 2018-10-30 2019-10-30 治療用化合物および組成物
JP2024185222A Pending JP2025011310A (ja) 2018-10-30 2024-10-21 治療用化合物および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024185222A Pending JP2025011310A (ja) 2018-10-30 2024-10-21 治療用化合物および組成物

Country Status (10)

Country Link
US (1) US20210261524A1 (https=)
EP (1) EP3873444A4 (https=)
JP (2) JP2022506110A (https=)
KR (1) KR20210087467A (https=)
CN (1) CN112996495A (https=)
AU (1) AU2019373237A1 (https=)
BR (1) BR112021008345A2 (https=)
CA (1) CA3117470A1 (https=)
IL (1) IL282766A (https=)
WO (1) WO2020092592A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2733405C2 (ru) 2014-02-07 2020-10-01 Экзитера Фармасьютикалз Инк. Терапевтические соединения и композиции
EP3749662A4 (en) 2018-02-07 2021-07-14 Exithera Pharmaceuticals Inc. THERAPEUTIC COMPOUNDS AND COMPOSITIONS
KR20210084581A (ko) * 2018-10-30 2021-07-07 엑시테라 파마슈티컬스 인코퍼레이티드 치료 화합물 및 조성물
IL301410A (en) * 2020-09-17 2023-05-01 Exithera Pharmaceuticals Inc FACTOR XIa OR KALLIKREIN INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE THEREOF
CN116782911A (zh) * 2020-09-17 2023-09-19 艾克赛特赫拉制药有限责任公司 治疗性化合物、组合物及其使用方法
TW202346278A (zh) * 2022-03-28 2023-12-01 大陸商四川海思科製藥有限公司 2-氨基吡啶衍生物製備方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802206D0 (sv) * 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
CA2648522A1 (en) * 2005-04-04 2006-10-12 Daiamed, Inc. Substituted azetidinones
WO2008124757A1 (en) * 2007-04-10 2008-10-16 Bristol-Myers Squibb Company Thiazolyl compounds useful as kinase inhibitors
KR101937514B1 (ko) * 2011-10-14 2019-01-10 브리스톨-마이어스 스큅 컴퍼니 인자 xia 억제제로서의 치환된 테트라히드로이소퀴놀린 화합물
RU2733405C2 (ru) * 2014-02-07 2020-10-01 Экзитера Фармасьютикалз Инк. Терапевтические соединения и композиции
US20190315711A1 (en) * 2016-12-23 2019-10-17 Exithera Pharmaceuticals, Inc. Therapeutic compounds and compositions

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021017939A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
JP2022506110A5 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112019016138A2 (https=)
BR112019016142A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)
AT524962A5 (https=)